Skip to content
Open access

GPR132 antagonists alleviate atherosclerosis by suppressing M1 polarization and subsequent VSMCs proliferation and migration as revealed by transcriptomic profiling

Aug 2026 · Inflammation Research · Vol 75 · 0 citations · 53 references
Medicine

TL;DR

Mechanistically, GPR132 drove M1 macrophage polarization primarily through activation of the p38/MAPK signaling pathway, an effect reversible by SB203580 or GPR132 antagonists, and its antagonism mitigates atherosclerotic progression by suppressing inflammatory microenvironments and VSMCs proliferation/migration.

Abstract

Atherosclerosis (AS) is a chronic inflammatory disorder with substantial global prevalence, wherein macrophage polarization and vascular smooth muscle cells (VSMCs) phenotypic switching are critical pathogenic events. Although G protein-coupled receptor 132 (GPR132) is markedly expressed in macrophages, its specific role and mechanism in AS-associated macrophage polarization remain incompletely understood. Pharmacological antagonism of GPR132 was evaluated in high-fat diet-fed ApoE−/− mice. Integrated single-cell RNA sequencing and transcriptome analyses from GEO datasets were performed to profile GPR132 expression in murine and human atherosclerotic plaques. In vitro, GPR132 overexpression and knockout macrophages were generated to assess M1/M2 polarization markers, and an indirect co‑culture system with VSMCs was established. Mechanistic investigations employed RNA‑sequencing and Western blotting, with pathway inhibition using SB203580 or GPR132 antagonists. GPR132 antagonism attenuated atherosclerotic lesion progression and reduced pro‑inflammatory cytokine secretion without altering lipid profiles. GPR132 was enriched in pro‑inflammatory (M1‑like) macrophage subpopulations within plaques, which also upregulated VSMC‑promoting growth factors. GPR132 overexpression promoted M1 macrophage polarization and suppressed IL‑4‑induced M2 macrophage polarization, whereas knockout enhanced M2 and attenuated M1. Conditioned medium from GPR132‑overexpressing macrophages significantly enhanced VSMCs proliferation and migration. Mechanistically, GPR132 drove M1 macrophage polarization primarily through activation of the p38/MAPK signaling pathway, an effect reversible by SB203580 or GPR132 antagonists. GPR132 promotes pro‑inflammatory macrophage polarization via p38/MAPK signaling, and its antagonism mitigates atherosclerotic progression by suppressing inflammatory microenvironments and VSMCs proliferation/migration, highlighting GPR132 as a potential therapeutic target for AS.

Read PDF

Similar papers

Nov 2026

GPR146 as a therapeutic target: Linking lipid metabolism with macrophage inflammation in atherosclerosis.

Atherosclerosis is driven by dyslipidemia and chronic inflammation. GPR146 has emerged as a regulator of cholesterol metabolism; however, whether GPR146 links lipid metabolism with macrophage inflammation during atherosclerosis remains unclear. Apolipoprotein E-deficient (ApoE-/-) mice were fed a high-fat diet for 12 w...

Qing Liu, Yi-Fei Wang, Yu Geng et al. · 0 citations
Open access Oct 2026

BDH1 Attenuates Macrophage Foam Cell Formation and Inflammation in Atherosclerosis Via Modulating Histone H3K9 Acylation Balance and Activating PPAR Signaling

β‐Hydroxybutyrate dehydrogenase 1 (BDH1) has been implicated in metabolic disorders. Nevertheless, its function and underlying mechanisms in atherosclerosis (AS) remain ambiguous. A high‐fat diet‐fed apolipoprotein E‐deficient mouse model and oxidized low‐density lipoprotein (ox‐LDL)‐induced RAW264.7 macrophages were e...

Yu Wang, Yi Wang, Qing-Hong Liu et al. · 0 citations
Sep 2026

IGF2BP3 drives macrophage M1 polarization to promote intracranial aneurysm rupture through m6A-mediated NPY1R stabilization.

BACKGROUND The progression of intracranial aneurysm (IA) was closely associated with an imbalance in M1/M2 macrophage polarization. Neuropeptide Y receptor 1 (NPY1R) was involved in regulating IA development. However, NPY1R in IA-associated macrophages and its impact on macrophage polarization remain to be elucidated....

Jian He, Ting Tang, Yong-Hong Duan et al. · 0 citations
Open access Oct 2026

Macrophage-derived TNF-α promotes vascular inflammation and cell crosstalk in human atherosclerotic plaques via TNFRSF1A.

AIMS Atherosclerosis (AS) is a chronic inflammatory disease driven by complex cellular crosstalk within plaques. How a key inflammatory pathway orchestrates multicellular vascular injury and whether this is conserved across vascular beds remains incompletely understood. METHODS Carotid and coronary plaques were profi...

Tao Wang, Chang-Tian Hu, Heng-Lei Xia et al. · 0 citations
Open access Sep 2026

Ilexoside K Ameliorates Atherosclerosis by Suppressing CD72hi Macrophages and Blocking CXCL12–CXCR4 Axis to Inhibit Endothelial Pyroptosis

ABSTRACT Atherosclerotic cardiovascular disease (ASCVD) remains the leading global cause of mortality, with substantial residual inflammatory risk persisting despite statin therapy. We identify a c‐Rel‐driven CD72hi macrophage subset markedly enriched in human and murine atherosclerotic plaques, whose abundance correla...

Xing-Ling He, Si-Jing Li, Jia-Hui Chen et al. · 0 citations
Nov 2026

APOC1 drives M2 macrophage polarization and prostate cancer progression via PPARG-IL-10 and is targeted by α-NAD.

The malignant progression of prostate cancer is closely linked to M2 polarization of macrophages within the tumor microenvironment; however, the upstream molecular drivers that specifically orchestrate this polarization in tumor-associated macrophages (TAMs) remain incompletely understood. This study aimed to investiga...

Tao Ma, Zuo-Run Xiao, Yue-Ran Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.